Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ISMP jeers CDRH

This article was originally published in The Gray Sheet

Executive Summary

The Institute for Safe Medication Practices condemns FDA's device center "for its continued failure, despite patient deaths and injuries," to ban "from all health care settings" infusion pumps without free-flow protection. CDRH's inaction on the issue prompts ISMP to include the center on the negative end of its 1998 list of "Cheers and Jeers." Last spring, the organization called on CDRH to withhold approval of pumps lacking a fail-safe mechanism designed to prevent uncontrolled free-flow of intravenous fluids ("The Gray Sheet" May 18, p. 34)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011067

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel